Related Experiment Video
Updated: Jul 19, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
A hierarchical screening methodology for physicochemical/ADME/Tox profiling
Robert S DeWitte1, Russell H Robins
1New Pharma R&D Solutions, Thermo Electron Corporation, 5344 John Lucas Drive, Burlington, Ontario L7L 6A6, Canada. robert.dewitte@thermo.com
To improve drug discovery, researchers developed a hierarchical screening strategy and automated system. This approach enhances preclinical profiling productivity and data reliability for faster decision-making.
Area of Science:
- Pharmaceutical Sciences
- Drug Discovery
- Preclinical Research
Background:
- Pharmaceutical profiling is crucial for lead selection and optimization, demanding comprehensive data for timely decisions.
- Increasing chemical synthesis and assay scope challenge labs to produce more data for accelerated drug development cycles.
- Balancing high-throughput data with accuracy is key for maintaining confidence in preclinical decision-making.
Purpose of the Study:
- To address the challenge of increasing preclinical profiling productivity.
- To manage lower accuracy, higher throughput data streams effectively.
- To propose and implement a strategy for efficient data generation in drug discovery.
Main Methods:
- Development of a hierarchical screening strategy.
- Implementation of an automated system to support the screening strategy.
- Focus on managing data streams for preclinical profiling.
Main Results:
- The proposed strategy and automated system aim to enhance preclinical profiling efficiency.
- The system is designed to support the hierarchical screening approach.
- Improved data management for decision-making in pharmaceutical lead selection.
Conclusions:
- A hierarchical screening strategy coupled with automation can improve preclinical profiling productivity.
- Efficient management of diverse data streams is essential for reliable drug discovery decisions.
- The implemented system supports accelerated decision-making in pharmaceutical development.
More Related Videos
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Related Concept Videos
Toxicokinetics: Overview
Toxicity Testing in Animals
Measurement of Bioavailability: Pharmacodynamic Methods
Measurement of Bioavailability: Pharmacokinetic Methods